Document is current

Article History

Received: 28 April 2023

Accepted: 27 September 2023

First Online: 14 October 2023

Declarations

:

: The survey was performed in accordance with relevant guidelines and in line with the principles of the Declaration of Helsinki. As this was an analysis of secondary data, specific IRB approval was not required. However, the NASH 2019 DSP was submitted to the Western IRB (protocol number AG8065) in the United States and an IRB exemption was granted.Data collection was undertaken in line with European Pharmaceutical Marketing Research Association [] guidelines and as such it does not require ethics committee approval. Each survey was performed in full accordance with relevant legislation at the time of data collection, including the US Health Insurance Portability and Accountability Act 1996 [], and Health Information Technology for Economic and Clinical Health Act legislation [].All patients provided written informed consent for use of their data, which were anonymized and aggregated. No medication was provided and no tests or investigations were performed as part of this research. No hypothesis was developed or tested.

: Participants provided informed consent regarding the publication of aggregated and deidentified data.

: Jesse Fishman is employed by Madrigal Pharmaceuticals. Victoria Higgins is employed by Adelphi Real World. James Piercy and James Pike are employed by Adelphi Real World.